Clinical Trial Update: Safety, PK, and PD of BSA204 in Chinese Adults With Borderline Elevated Lipoprotein(a) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety, pharmacokinetics, and pharmacodynamics of BSA204 in Chinese adults with borderline elevated lipoprotein(a).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• BSA204

Snippet

Sponsor: Bisirna Therapeutics (Suzhou) Co., Ltd. | Conditions: Dyslipidemias | Phase 1 | Status: NOT_YET_RECRUITING